Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126482761 | 12648276 | 1 | I | 20160811 | 20160812 | 20160812 | EXP | GB-MHRA-ADR 23590668 | GB-009507513-1608GBR006912 | MERCK | 69.00 | YR | F | Y | 0.00000 | 20160812 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126482761 | 12648276 | 1 | PS | LOSARTAN POTASSIUM. | LOSARTAN POTASSIUM | 1 | Oral | U | U | 20386 | TABLET | ||||||||
| 126482761 | 12648276 | 2 | SS | ADIZEM | DILTIAZEM HYDROCHLORIDE | 1 | U | U | 0 | ||||||||||
| 126482761 | 12648276 | 3 | SS | RAMIPRIL. | RAMIPRIL | 1 | U | U | 0 | ||||||||||
| 126482761 | 12648276 | 4 | C | BENDROFLUMETHIAZIDE | BENDROFLUMETHIAZIDE | 1 | UNK | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126482761 | 12648276 | HO |
| 126482761 | 12648276 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126482761 | 12648276 | Aphonia | |
| 126482761 | 12648276 | Hypokalaemia | |
| 126482761 | 12648276 | Pneumonia | |
| 126482761 | 12648276 | Syncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126482761 | 12648276 | 4 | 201607 | 0 |